PetMed ExpressPETS
About: PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
Employees: 287
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
765% more call options, than puts
Call options by funds: $1.51M | Put options by funds: $174K
5.29% less ownership
Funds ownership: 43.3% [Q4 2024] → 38.01% (-5.29%) [Q1 2025]
16% less funds holding
Funds holding: 85 [Q4 2024] → 71 (-14) [Q1 2025]
24% less capital invested
Capital invested by funds: $43.1M [Q4 2024] → $32.9M (-$10.2M) [Q1 2025]
48% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 27
62% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 21
Research analyst outlook
We haven’t received any recent analyst ratings for PETS.
Financial journalist opinion
Based on 16 articles about PETS published over the past 30 days









